Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453518 · ClinicalTrials.gov registry record · NA
The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts
A NA study, sponsored by Lumen Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT00453518 is a NA study that has completed, run by Lumen Biomedical. The registered enrollment target is 29 participants.
The verdict
NCT00453518, a NA study, has completed, sponsored by Lumen Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This is a multicenter, prospective study designed to demonstrate the performance and safety of the FiberNet Embolic Protection System when used as an adjunctive device during saphenous vein graft (SVG) intervention.
Interventions
- DEVICE FiberNet EPS used during SVG intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00453518
The ClinicalTrials.gov registry entry for NCT00453518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumen Biomedical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FiberNet EPS used during SVG intervention. is the first listed.
NCT00453518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00453518 about?
NCT00453518 is a clinical study titled "The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts". This is a multicenter, prospective study designed to demonstrate the performance and safety of the FiberNet Embolic Protection System when used as an adjunctive device during saphenous vein graft (SVG) intervention.
What is the current status of trial NCT00453518?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2007-03. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00453518?
The interventions under investigation include: FiberNet EPS used during SVG intervention. (DEVICE).
Who is sponsoring clinical trial NCT00453518?
This trial is sponsored by Lumen Biomedical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.